Investment
Features
FeesSafety
Academy
More
Pluang+

Ethereum to speed up block times from 12 to 10 seconds in 2027 upgrade, backed by institutional investors.

Protocol Fundamentals
18 Sep 2026
Crypto Briefing
View Source
Bullish
Ethereum to speed up block times from 12 to 10 seconds in 2027 upgrade, backed by institutional investors.

Ethereum Institutional supports EIP-8198, a proposal by Ethlabs to reduce Ethereum's block time from 12 seconds to 10 seconds as part of the Hegotá upgrade planned for 2027. This change aims to speed up transaction confirmation, benefiting institutional users by reducing trading risks and improving execution. The proposal also introduces a flexible parameter for future block time adjustments without major upgrades. Broad ecosystem support has been reported, with no major concerns about decentralization or validator participation.

Ethereum Institutional's proposal to reduce block times is presented here alongside Pluang's market data as of Sep 18, 2026 20:01 WIB. Among 50 major cryptocurrencies priced on Pluang, 46 rose and 3 fell today. Notable movers include SAND at Rp681 with an 11.37% increase, BAL at Rp16.297 up 11.14%, and AAVE at Rp2.437.108 rising 10.91%.

More News

Duke Energy's stock shows 8.26% upside with strong earnings forecast and mixed institutional interest.

Duke Energy's stock shows 8.26% upside with strong earnings forecast and mixed institutional interest.

Duke Energy Corporation's stock is projected to rise about 8.26% to a price target of $127, down slightly from $133, reflecting confidence despite a recent price dip. The company expects a 4.42% increase in earnings per share to $1.89 and a 3.86% ris...

Analyst Insights
Bullish
32 minutes ago
Xenon Pharmaceuticals stock plunges 27.6% after pausing clinical trials due to safety concerns.

Xenon Pharmaceuticals stock plunges 27.6% after pausing clinical trials due to safety concerns.

Xenon Pharmaceuticals halted new patient enrollment in its psychiatry clinical trials for the drug azetukalner after reports of neuropsychiatric side effects. This pause led to a sharp 27.6% drop in its stock price, marking its worst day since 2017. ...

Market News
Bearish
1 hour ago
Innate Pharma beats EPS estimates and secures $75M deal with Sobi, boosting cash runway to 2028

Innate Pharma beats EPS estimates and secures $75M deal with Sobi, boosting cash runway to 2028

Innate Pharma reported an EPS of -$0.24, beating analyst estimates of -$0.29, and revenue of $6.5 million, slightly above expectations. The company secured a strategic partnership with Sobi for its drug lacutamab, receiving a $75 million upfront paym...

Company Fundamentals
Bullish
1 hour ago
Paychex to report Q1 2027 earnings with expected EPS of $1.32 and $1.63B revenue on Sept 23

Paychex to report Q1 2027 earnings with expected EPS of $1.32 and $1.63B revenue on Sept 23

Paychex, a provider of human capital management solutions, will release its Q1 fiscal 2027 earnings on September 23, 2026. Analysts expect earnings per share (EPS) of $1.32, up from $1.22 last year, and revenue of about $1.63 billion, higher than las...

Company Fundamentals
Bullish
2 hours ago
Barclays cuts Lennar price target to $70 amid weak Q3 earnings and housing market challenges

Barclays cuts Lennar price target to $70 amid weak Q3 earnings and housing market challenges

Barclays lowered its price target for Lennar Corporation to $70 from a higher level, citing a 52% drop in Q3 net earnings to $284 million and an 8.6% revenue decline to $8.05 billion. The homebuilder faces headwinds from rising mortgage rates and wea...

Analyst Insights
Bearish
3 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App